African Journal of Infectious Diseases Research

ISSN 2756-3340

African Journal of Infectious Diseases Research | Vol. 12, No. 7, July 2025 | pp. 474–480

DOI: 10.46882/AJIDR/148831

Article Type: Research Article

Title: Prevalence and risk factors of Clostridioides difficile infection among hospitalized patients receiving broad-spectrum antibiotic therapy

Names of Authors: Oluwaseun Balogun¹*, Henriette Dubois², Hiroshi Tanaka³

Authors’ Affiliations: ¹Department of Medical Microbiology, Lagos State University College of Medicine, Ikeja, Nigeria. ²Department of Infectious Diseases, University of Bordeaux, Bordeaux, France. ³Department of Gastroenterology, Osaka University, Osaka, Japan.

Abstract: Clostridioides difficile is a primary cause of healthcare-associated diarrhea following disruption of normal gut microbiota by antimicrobial agents. We determined the incidence, toxin gene profiles, and clinical predictors of C. difficile infection among hospitalized adults developing antibiotic-associated diarrhea. Stool samples from 285 patients were screened using glutamate dehydrogenase enzyme immunoassays and multiplex polymerase chain reaction targeting tcdA and tcdB genes. Toxigenic C. difficile was confirmed in 16.8 percent of patients, strongly associated with prolonged third-generation cephalosporin use, proton pump inhibitor co-administration, and advanced age. Strengthening antimicrobial stewardship and contact isolation protocols is essential to curb nosocomial transmission.

Keywords: Clostridioides difficile, Antibiotic-associated diarrhea, Nosocomial infection, Antimicrobial stewardship, Toxin genes

Citation: Balogun O, Dubois H, Tanaka H (2025). Prevalence and risk factors of Clostridioides difficile infection among hospitalized patients receiving broad-spectrum antibiotic therapy. African Journal of Infectious Diseases Research, 12(7): 474–480. DOI: 10.46882/AJIDR/148831

Manuscript Timeline: Received: May 16, 2025; Revised: June 17, 2025; Accepted: June 30, 2025; Published: July 03, 2025